• 1
    Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Bethesda, MD: National Heart, Lung and Blood Institute, 2002. NIH Publication, N 02-3659: 1–197.
  • 2
    Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:11941200.
  • 3
    Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418424.
  • 4
    Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:17201745.
  • 5
    Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219224.
  • 6
    Van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207212.
  • 7
    Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri O, Pozzi E et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356: 20402052.
  • 8
    Eda R, Sugiyama H, Hopp RJ, Okada C, Bewtra AK, Townley RG. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. Int Arch Allergy Immunol 1993;102:391398.
  • 9
    Mita H, Shida T. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue. Allergy 1983;38:547552.
  • 10
    Caramori G, Adcock IM. Pharmacology of airway inflammation in asthma and COPD. Pulm Pharmacol Ther 2003;16:247277.
  • 11
    Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 2002;110:S282S290.
  • 12
    Oddera S, Silvestri M, Sacco O, Lantero S, Morelli MC, Rossi GA. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatics patients. Ann Allergy Asthma Immunol 1995;75:3340.
  • 13
    Linden M, Brattsand R. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1ß and IL-6. Pulm Pharmacol 1994;7:4347.
  • 14
    Miyamasu M, Misaki Y, Izumi S, Takaishi T, Morita Y, Nakamura H et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 1998;101:7583.
  • 15
    Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C. Comparative study of the effects of different gluco-corticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995;50:270274.
  • 16
    Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139:359370.
  • 17
    Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur Respir J 2000;15:6874.
  • 18
    Oddera S, Cagnoni F, Mangraviti S, Giron-Michel J, Popova O, Canonica GW. Effects of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule expression and mediator release. Int Arch Allergy Immunol 2002;129:152159.
  • 19
    Leis M, Marschall M, Stamminger T Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol 2004;85:19952000.
  • 20
    Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001;7:213221.
  • 21
    Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E et al. Resolution of lung inflammation by CD44. Science 2002;296:155158.
  • 22
    Sacco O, Silvestri M, Sabatini F, Sale R, Defilippi AC, Rossi GA. Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev 2004;5(Suppl. A):S35S40.
  • 23
    Cazes E, Giron-Michel J, Baouz S, Doucet C, Cagnoni F, Oddera S et al. Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation. J Immunol 2001;167:53295337.
  • 24
    Profita M, Gagliardo R, Di Giorgi R, Pompeo F, Gjomarkaj M, Nicolini G et al. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. Allergy 2005;60:323329.
  • 25
    Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998;10:14211433.
  • 26
    Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998;101:21292139.
  • 27
    Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, Olsson S et al. Lung myofibroblasts as targets of salmeterol and fluticasone propinate: inhibition of alpha-SMA and NF-kappaB. Int Immunol 2005;17:14731481.
  • 28
    Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002;57:237241.
  • 29
    Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998;28:568577.
  • 30
    Todorova L, Gurcan E, Miller-Larsson A, Westergren-Thorsson G. Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. Am J Respir Cell Mol Biol 2006;34:92100.
  • 31
    Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M et al. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999;274:10051010.
  • 32
    Hagood JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH et al. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 2005;167:365379.
  • 33
    Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825857.
  • 34
    Romberger DJ et al. Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-beta. Am J Respir Cell Mol Biol 1992;7:149155.